id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-N-1189-0004,FDA,FDA-2023-N-1189,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:26:13Z,2023-28290,0,0,09000064863516f6
FDA-2023-N-1189-0003,FDA,FDA-2023-N-1189,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Importation of Prescription Drugs,Notice,30 Day Proposed Information Collection,2023-10-13T04:00:00Z,2023,10,2023-10-13T04:00:00Z,2023-11-14T04:59:59Z,2023-10-16T13:17:53Z,2023-22653,0,0,09000064860cde33
FDA-2023-N-1189-0001,FDA,FDA-2023-N-1189,"Agency Information Collection Activities; Proposed Collection; Comment Request; Importation of
Prescription Drugs",Notice,60 Day Proposed Information Collection,2023-06-08T04:00:00Z,2023,6,2023-06-08T04:00:00Z,2023-08-08T03:59:59Z,2023-08-08T01:02:56Z,2023-12258,0,0,0900006485adea5d